Cytotrait appoints Dr Ian Jepson as non-executive director
Dr Jepson previously held senior R&D roles at Syngenta and will support Cytotrait's MOSS platform strategy. The company also cited its £3 million seed round in 2026 as it seeks new crop trait programmes and partnerships.